WHAT WE ARE LOOKING FOR

In-licensing, co-marketing, co-promotion or acquisition of

 

  • New CNS pharmaceuticals with unique selling propositions
  • New medical devices (CNS)
  • Late-stage CNS clinical projects (phase II b or III) for co-development
  • Pediatric or CNS orphan drugs
  • Dermatology Rx-products with unique selling propositions
  • Pharmaceuticals with special application forms
  • Established branded pharmaceuticals  

 

 

CONTACT DESITIN IF…

...you want to be successful with your product in Europe in a specialist target group!